Biography
Biography: Suprava Patel
Abstract
Cancer is still one of the major causes of mortality throughout the world. Over 200 types of cancers have been currently identified because of recent developments in cancer diagnostic technologies. In-spite growing advancement in therapeutic aspects, death incidences are still rising where early detection of cancer being a major limitation. Currently, many cancers are diagnosed only after they have advanced to metastasis. Various cancer biomarkers have been reported to play an important role in clinical oncology in terms of diagnosis, treatment monitoring and prognostic marker. Biosensors have been highlighted by many researchers as a wonder devise as it is quite simple and can identify a specific biological entity by converting it into an electrical signal that can be sensed and analyzed. Besides, it can also be designed to detect new emerging cancer biomarkers and detect the effectiveness of chemotherapeutic agents at its target site. Biosensor technology has the potential to provide highly sensitive & rapid diagnostic tool, for early detection of cancer, determine the effectiveness of anticancer drugs and monitoring prognosis. It will be briefly summarized about the recent advances of biosensor technology as a diagnostic tool taking into account the limitations as well as its future perspective.
